Showing results (71-80 of 284) with videos related to

Sort By:
Pageof 29
Journal of Neural Transmission (Vienna, Austria : 1996)|January 10, 2024
Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson's diseaseMakoto Naoi, Wakako Maruyama, Masayo Shamoto-Nagai, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 14, 2012
What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's researchMelita Salkovic-Petrisic, Ana Knezovic, Siegfried Hoyer, et al.
CNS & Neurological Disorders Drug Targets|March 25, 2015
Lewy Bodies: A Spectator or Salient Killer?Jeswinder Sian-Hulsmann, Camelia Monoranu, S Strobel, et al.
Attention Deficit and Hyperactivity Disorders|April 4, 2014
A short review on the relation between the dopamine transporter 10/10-repeat allele and ADHD: implications for HIV infectionEleni Koutsilieri, Peter Riederer, Stefan du Plessis, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 2, 2024
Type A monoamine oxidase; its unique role in mood, behavior and neurodegenerationMakoto Naoi, Wakako Maruyama, Masayo Shamoto-Nagai, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 27, 2015
Driving skills in unmedicated first- and recurrent-episode schizophrenic patientsFelix M Segmiller, Verena Buschert, Gerd Laux, et al.
Planta Medica|March 8, 2003
Constituents of sage (Salvia officinalis) with in vitro affinity to human brain benzodiazepine receptorDominique Kavvadias, Vanessa Monschein, Philipp Sand, et al.
Experimental Neurology|June 30, 2006
Oxidative stress in the brain at early preclinical stages of mouse scrapieSeong-Wook Yun, Manfred Gerlach, Peter Riederer, et al.
Clinical Drug Investigation|June 22, 2012
Therapeutic drug monitoring of antidepressants in haemodialysis patientsStefan Unterecker, Philip Müller, Christian Jacob, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 12, 2012
Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathwaysJasmin Bartl, Andrea Meyer, Svenja Brendler, et al.
Pageof 29